- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04844021
Adolescent and Child Suicide Prevention in Routine Clinical Encounters (ASPIRE)
A Comparative Effectiveness Trial of Strategies to Implement Firearm Safety Promotion as a Universal Suicide Prevention Strategy in Pediatric Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will conduct a hybrid type III effectiveness-implementation trial using a longitudinal cluster randomized design to test the most effective way to implement S.A.F.E. Firearm among 30 clinics, 158 clinicians, and 48,475 youth nested in two Mental Health Research Network (MHRN) health systems in Michigan and Colorado. Clinics will be randomized to receive either the EHR implementation strategy (Nudge) or the EHR implementation strategy plus 1 year of facilitation to target implementation barriers (Nudge+).
Aim 1: Examine the effects of Nudge vs. Nudge+ on implementation outcomes.
- Reach: The investigators hypothesize that clinician-documented program delivery in the EHR (reach; primary outcome) will be superior in the Nudge+ condition compared to Nudge in the active and sustainment periods.
- Fidelity: The investigators hypothesize that parent-reported clinician fidelity to the program will be superior in the Nudge+ condition compared to Nudge in the active and sustainment periods.
- Cost: The investigators will also assess implementation strategy cost.
- Cable Locks/Acceptability: The investigators hypothesize that the Nudge+ condition will result in increased rates of cable lock distribution and higher acceptability compared with Nudge in both the active and sustainment periods.
Aim 2: Use mixed methods to identify implementation strategy mechanisms. The investigators hypothesize that Nudge+ will have a stronger effect because it will improve clinic adaptive reserve (i.e., the ability to make and sustain change). The investigators will also investigate the role of clinician motivation. The investigators hypothesize that clinician attitudes towards firearm counseling, clinician burnout, and clinician demographics will moderate implementation strategy effectiveness.
Aim 3: Examine the effects of the adapted intervention on clinical outcomes. The investigators hypothesize that Nudge+ will result in a greater proportion of parents reporting that they made firearm(s) less accessible to their child(ren) compared with Nudge. The investigators will explore rates of youth suicide attempts, deaths, and unintentional firearm injury and mortality by implementation condition and across time.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80014
- Kaiser Permanente Colorado
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria: Parents
- Parents and/or legal guardians (hereafter referred to as parents) at participating pediatric clinics who have a child age 5-17 who attends a well visit. At least one parent must attend the well visit to be eligible. The parent must be at least 18 years old to participate.
Exclusion Criteria: Parents
- Due to translation costs and challenges of recruiting non-US resident participants, respectively, non-English speaking parents and non-US resident parents will not be eligible to participate at Henry Ford Health System.
Inclusion Criteria: Clinicians and leaders
- Pediatric physicians and non-physician clinicians (hereafter referred to as clinicians) employed within the participating pediatric clinics, as well as health system leaders employed within the two health systems, are eligible to participate. Family medicine clinicians who see pediatric patients in participating clinics at Kaiser Permanente Colorado will also be eligible.
Exclusion criteria: Clinicians and leaders
- At Kaiser Permanente Colorado, family medicine clinicians whose patient panel is comprised of fewer than 5% pediatric patients will be excluded.
- Family medicine clinicians who see pediatric patients in participating clinics at Henry Ford Health System will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nudge
Clinics randomized to the Nudge condition will receive the EHR prompt only.
The investigators will add default language to the standard Well Child Visit workflow to serve as a reminder and allow for tracking of S.A.F.E.
Firearm implementation.
The clinician will be asked to denote whether the program was delivered (e.g., whether conversation around firearm storage was conducted, whether cable firearm lock was offered) to the parent during the visit.
This EHR prompt will remain turned "on" from active implementation through the sustainment period.
|
EHR-based "nudge"
|
Experimental: Nudge+
This arm consists of Nudge as described above, as well as facilitation.
Facilitation (i.e., external support delivered by health system employees not employed within the clinic site) will be offered for 12 months to each clinic, in keeping with other implementation trials.
The investigators will use a train-the-trainer model to train facilitators at both health systems to ensure they achieve facilitator core competencies with an eye toward implementation of S.A.F.E.
Firearm.
The role of the facilitator is to engage with study clinics, to assist each clinic in setting change and performance goals around the implementation of S.A.F.E.
Firearm, and to troubleshoot implementation barriers.
|
EHR-based "nudge" plus facilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach
Time Frame: EHR data on reach will be extracted for the time period: the beginning of the active implementation period through the sustainment period (24 months total)
|
Number of parent-youth dyads who receive the S.A.F.E.
firearm program divided by number of eligible parent-youth dyads (extracted from EHR)
|
EHR data on reach will be extracted for the time period: the beginning of the active implementation period through the sustainment period (24 months total)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fidelity
Time Frame: surveys collected from parents within two weeks of well-child visit. Surveys will be collected during the duration of the pre-implementation, active implementation, and sustainment phases (30 months total)
|
Whether the clinician followed the two S.A.F.E.
Firearm steps (counseling and offering cable lock), measured via parent-report
|
surveys collected from parents within two weeks of well-child visit. Surveys will be collected during the duration of the pre-implementation, active implementation, and sustainment phases (30 months total)
|
Parent-reported acceptability
Time Frame: Parent surveys will be collected from parents within two weeks of well-child visit from pre-implementation through sustainment (30 months total)
|
Parent-report of acceptability of the S.A.F.E.
Firearm program.
Parents will be asked to answer questions pertaining to the acceptability of program components.
Specifically, they will answer yes/no questions developed by the research team which ask whether they found the component acceptable.
|
Parent surveys will be collected from parents within two weeks of well-child visit from pre-implementation through sustainment (30 months total)
|
Clinician-reported acceptability
Time Frame: Clinician surveys will be collected at two time points during the study period: during pre-implementation (surveys will be administered for approximately 1 month) and during active implementation (surveys will be administered for approximately 1 month)
|
Clinician-report of acceptability of the S.A.F.E.
Firearm program.
Acceptability of the implementation strategies - EHR nudge and facilitation - will be collected from clinicians as well.
Clinicians will be asked questions developed by the research team about whether they found various components of the program and implementation strategies acceptable, and will answer each question with a Likert-scaled answer.
|
Clinician surveys will be collected at two time points during the study period: during pre-implementation (surveys will be administered for approximately 1 month) and during active implementation (surveys will be administered for approximately 1 month)
|
Cost
Time Frame: Cost data will be collected from pre-implementation through sustainment (30 months total)
|
Cost of the implementation strategies (EHR nudge, facilitation) and the S.A.F.E.
Firearm program delivery.
Data on the cost of implementing the program (e.g., costs for printing program materials and distributing firearm locks) and the implementation strategies (e.g., facilitator full-time equivalent [FTE] time) will be collected to estimate the overall cost of the program and implementation strategy delivery.
|
Cost data will be collected from pre-implementation through sustainment (30 months total)
|
Distribution of cable locks
Time Frame: Cable lock distribution data will be collected from active implementation through sustainment (24 months total)
|
Number of cable locks distributed by each clinic will be collected
|
Cable lock distribution data will be collected from active implementation through sustainment (24 months total)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH123491 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Vestre Viken Hospital TrustSouth-Eastern Norway Regional Health AuthorityActive, not recruitingEcological Momentary Assessment | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionNorway
-
Mental Health Services in the Capital Region, DenmarkCompletedSuicide Prevention | Suicidal Thoughts | Suicide AttemptsDenmark
-
VA Office of Research and DevelopmentNot yet recruitingSuicidal Ideation | Suicide Attempt | Suicide PreventionUnited States
-
Franciscan Hospital For Children, INC.National Institute of Mental Health (NIMH); Harvard UniversityRecruitingSuicidal Ideation | Self-Injurious Behavior | Suicide AttemptsUnited States
-
Boston UniversityUnited States Department of Defense; The University of Texas Health Science... and other collaboratorsNot yet recruiting
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Henry Ford Health System; HealthPartners...Enrolling by invitationSuicide, Attempted | Suicide, FatalUnited States
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
Clinical Trials on Nudge
-
University of PennsylvaniaCompletedControl Condition | How Incentive Receive | How Incentive Holdout | How Incentive Ineligible | How and Why Incentive Receive | How and Why Incentive Holdout | How and Why Incentive IneligibleUnited States
-
RANDUniversity of California, Los Angeles; Northwestern University; University of... and other collaboratorsUnknownFall | Congestive Heart Failure | Adverse Drug Event | Chronic Kidney FailureUnited States
-
Children's Mercy Hospital Kansas CityNemours Children's Clinic; University of KansasNot yet recruiting
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingCardiovascular Diseases | Coronary Artery Disease | Hypertension | Diabetes Mellitus | Atrial Fibrillation | Hyperlipidemias | Medication Adherence | Adherence, MedicationUnited States
-
Abramson Cancer Center at Penn MedicineAstraZeneca; National Comprehensive Cancer NetworkRecruiting
-
Abramson Cancer Center at Penn MedicineEnrolling by invitationBreast CancerUnited States
-
Rio de Janeiro State UniversityUniversity of Copenhagen; Oswaldo Cruz Foundation; Universidade Federal do Rio...Suspended
-
Northwestern UniversityUniversity of California, Los Angeles; National Institute on Aging (NIA); University... and other collaboratorsEnrolling by invitationPolypharmacyUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)CompletedCancerUnited States
-
Abramson Cancer Center at Penn MedicineNational Institute on Drug Abuse (NIDA); University of PennsylvaniaEnrolling by invitationSmoking | Tobacco Use | HIV | Nicotine DependenceUnited States